How many patents does
Buck Institute For Research On Aging have?
patents
255
families
39
granted
42
applications
213
US
85
WO
33
EP
32
JP
13
CN
12
KR
5
GB
1
RoW
74
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Buck Institute For Research On Aging
Top ten assignees appearing on patents
2009 - 2018
| unity biotechnology | 38 |
| biotica technology | 28 |
| biotica tech | 3 |
| delos pharmaceuticals | 3 |
| wyeth | 2 |
| biotika teknolodzhi | 2 |
| kythera biopharmceuticals | 2 |
| biotica tecnology | 1 |
| cenexys | 1 |
| unity biotechnolgoy | 1 |
2009
| biotica technology | 2 |
| biotica tecnology | 1 |
| biotica tech | 1 |
2018
| unity biotechnology | 16 |
| delos pharmaceuticals | 2 |
Buck Institute For Research On Aging
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods and compositions for killing senescent cells and for treating senescence-associa… 🛈 | 38 | 2014 |
| 39-desmethoxy derivatives of rapamycin | 19 | 2005 |
| production of polyketides and other natural products | 16 | 2002 |
| methods for improving medical therapies | 16 | 2011 |
| app specific bace inhibitors (asbis) and uses thereof | 15 | 2012 |
| hydantoins that modulate bace-mediated app processing | 15 | 2013 |
| 17-desmethylrapamycin and analogues thereof, methods for their production and their use … 🛈 | 13 | 2004 |
| novel rapamycin analogue | 11 | 2011 |
| triazolopyridines and triazolopyrimidines that lower stress-induced p-tau | 10 | 2015 |
| compounds and uses in treatment of senescence-associated conditons | 10 | 2015 |